Shandong Province Centers for Disease Control and Prevention
13
1
1
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
62%
8 trials in Phase 3/4
11%
1 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Safety Study of Quadrivalent Subunit Influenza Vaccine in People Aged 3 Years and Older
Role: collaborator
Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)
Role: collaborator
Heterologous Boost Immunization with an Aerosolised Ad5-nCoV After Two-dose Priming with an Inactivated SARS-CoV-2 Vaccine
Role: collaborator
A Study on Immunity Duration Against Polio Over 18 Months Infants After 2 or 3 Primary Doses Sabin IPV in China
Role: collaborator
Immunogenicity and Safety of Two Different Commercial EV71 Vaccines
Role: collaborator
Sero-conversion Study for a Two-dose Schedule of Sabin IPV in China
Role: collaborator
A Study of Immunogenicity and Seroconversion With Sabin IPV Schedules in China.
Role: collaborator
Crowdsourcing A Public Health Campaign
Role: collaborator
Clinical Study on Combined Immune Effect of EV71 Inactivated Vaccine
Role: lead
Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
Role: collaborator
Shandong and Ministry of Health Action on Salt and Hypertension Project
Role: collaborator
Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-treatment Patients With Chronic Hepatitis C：An Open-label Control Study in China
Role: lead
A Non-inferiority Randomized Controlled Trial to Evaluate Promoting Condom Use Among MSM and Transgender Individuals in China
Role: collaborator
All 13 trials loaded